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Abstract—Background and Objective: A system level view of
cellular processes for human and several organisms can be cap-
tured by analyzing molecular interaction networks. A molecular
interaction network formed of differentially expressed genes and
their interactions helps to understand key players behind disease
development. So, if the functions of these genes are blocked
by altering their interactions, it would have a great impact in
controlling the disease. Due to this promising consequence, the
problem of inferring disease causing genes and their pathways has
attained a crucial position in computational biology research.
However, considering the huge size of interaction networks,
executing computations can be costly. Review of literatures shows
that the methods proposed for finding the set of disease causing
genes could be assessed in terms of their accuracy which a perfect
algorithm would find. Along with accuracy, the time complexity
of the method is also important, as high time complexities would
limit the number of pathways that could be found within a
pragmatic time interval.
Methods and Results: Here, the problem has been tackled by
integrating graph theoretical approaches with an approximation
algorithm. The problem of inferring disease causing genes and
their pathways has been transformed to a graph theoretical
problem. Graph pruning techniques have been applied to get
the results in practical time. Then, randomized rounding, an
efficient approach to design an approximation algorithm, has
been applied to fetch the most relevant causal genes and path-
ways. Experimentation on multiple benchmark datasets has been
demonstrated more accurate and computationally time efficient
results than existing algorithms. Also, biological relevance of these
results has been analyzed.
Conclusions: Based on computational approaches on biological
data, the sets of disease causing genes and corresponding path-
ways are identified for multiple disease cases. The proposed
approach would have a remarkable contribution in areas like
drug development and gene therapy, if we could recognize these
results biologically too.
Index Terms—Molecular interaction Network; Causal genes;
Dysregulated pathway; Graph pruning; Approximation algo-
rithm; Randomized rounding
I. INTRODUCTION
Cellular processes are mainly governed by the co-action
of biomolecules. For example, a particular protein function
can be understood by mapping protein-protein interactions.
These biological communications can be represented using
molecular interaction networks. At present, molecular
interaction networks of various organisms are available [1].
We can exploit them for diverse aims such as discovering
disease causing genes and related pathways. From the
computational perspective, computing information flows in
a complex model is expensive as the input sizes are large
and the analyses typically have very high time complexities.
Therefore, proposing algorithms for effective computation
on the networks would have a remarkable impact on
the knowledge to be gained from such networks. The
problem of inferring disease causing genes and dysregulated
pathways is of prime importance and huge academic and
industrial interest, because, it is potentially very useful for
comprehending the underlying system of complex diseases
and suggesting prospective drug targets. An algorithm that
augments graph theoretical approaches with approximation
for inferring causal genes and dysregulated pathways is
addressed in this paper. The proposed method incorporates
gene expression value because of its potentiality in predicting
diseases. High-risk genes are more correlated with each
other than the genes with lower risk and vice versa [2]. An
experimental analysis of the state of the art related works
together with the proposed method is also given in this paper.
Related works are based on Random walk based approach,
Electric circuit model with Expression Quantitative Loci
(eQTL) analysis, Electric circuit model with multiple sources
and sinks, Fast iterative matrix inversion and Approximation
algorithm based on Randomized rounding [3], [4], [5], [6],
[1], [7], [8], [9].
Proposed by Tu et al., the random walk approach has shown
a significant impact in the problem of identifying causal genes
and and the underlying pathways [1], [3], [4], [6]. Based
on the Pearson’s correlation coefficient of gene expression
values of genes, transition probability is defined. Starting
from a source node, random walker moves to a node that
is qualified as an unvisited and highest transition probability
bearing node among all the neighbors of the current node.
This process is repeated until it visits the destination node or
further movement is not possible. Candidate causal gene that
has the largest number of visit times or that has the largest
value of probability of being a causal gene is taken as the
causal gene, gc. Identification of pathway is done by tracing
a path from gc to the corresponding source node by selecting
intermediate nodes as the most visited ones. According to
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Suthram et al., this approach results in relatively short walks
with the requirement of multiple iterations for better results
[6]. They proposed a new approach based on Electric circuit
model which is analogous to Random walk based approach
[6], [1], [5], [3]. Considering a network of protein-protein
interactions and Transcription Factor (TF)-DNA interactions as
an electric circuit, conductance of each edge (u, v) is set based
on the correlation of expression values of u and v with the
target gene. After solving the electric circuit using Kirchhoff’s
and Ohm’s Laws to get the current through each node and
edge, the causal gene is taken as the gene with highest value
of current flow. Pathway is the shortest route between a target
gene and causal gene with the highest total sum of currents
across its interactions such that each edge corresponds to an
interaction. All such paths together give the textitpathways
for the entire network.
Based on the above approaches, Y. A. Kim et al. suggested
an electric circuit based approach with multiple sources and
sinks [1], [7]. Conductance is defined as the average of the
absolute value of the Pearson correlation coefficient between
gene expression values of target gene and genes at the end-
points of each link. A system of linear equations based on
Ohm’s law and Kirchhoff’s law is solved to find the voltages of
links and thereby to calculate the current value. Causal genes
are taken as the genes with significant amount of current flow.
Pathway is the shortest paths in the collection of all maximum
current paths for each pair of source and sink. Focusing on
the faster computation of voltages of nodes suggested in the
previous approach, a fourth order iterative method for fast
iterative matrix inversion was proposed in [8]. Following the
calculation of voltages of nodes, causal genes and dysregulated
pathways are identified as in citeref:yoo, [7].
A new approximation algorithm was proposed in [9], based
on electric circuit approach to fetch causal genes and cor-
responding pathways. Collection of all distinct paths in a
reduced network obtained by thresholding the edge-weights
is computed. Then, randomized rounding is applied to get
the path with maximum current flow which is taken as the
dysregulated pathway for the corresponding target and causal
genes. The members of the pathways are taken as causal
genes.
Here, we infer that the reported works in literature for
finding the set of disease causing genes could be evaluated
in terms of their accuracy, i.e, the closeness of the set found
to the actual set and execution time. During the assessment,
it has been observed that in most of the cases, execution time
rises with accuracy.
II. MATERIALS AND METHODS
A. Selection of target genes and candidate causal genes
Gene expression data of Breast cancer and Lung cancer
of the species Homosapiens (GSE44024 and GSE43459)
and Pancreatic cancer of the species Rattus norvegicus
(GSE22537) have been utilized for experimentation. Data have
been collected from the National Center for Biotechnology
Information (NCBI) sponsored Gene Expression Omnibus data
repository [9]. Platform details and sample information of the
datasets are given in Table ??.
Disease GEO Accession Sample count(case / control) Platform
Breast cancer GSE44024 4 (2 / 2)
GPL571
(Affymetrix
Human Genome
U133A 2.0 Array)
Lung cancer GSE43459 6 (3 / 3)
GPL6244
(Affymetrix
Human Gene
1.0 ST Array)
Pancreatic cancer GSE22537 18 (9 / 9)
GPL1355
(Affymetrix
Rat Genome
230 2.0 Array)
TABLE I: Dataset details
The following steps have been done for each dataset sep-
arately. The initial data have been normalized using Robust
Multi-array Average method to remove any noise due to
non-biological factors [10]. Then, the genes having statistical
significance have been selected using t-test with equal variance
and 2-tailed followed by the calculation of p-value. Then,
significant q-values have been computed and genes with q-
value < 0.05 have been selected. This set of differentially
expressed genes has been taken as the candidate causal genes
for Breast cancer and Pancreatic cancer. Considering the data
size, first 100 genes after sorting p-value in ascending order
following the filtering based on q-value, have been selected
as candidate causal genes for Lung cancer. Gene interac-
tion network of molecular interactions has been downloaded
from BioGRID database for each candidate causal gene. The
fetched network data have been filtered to select only the genes
that are differentially expressed. Genes that are linked with
transcription factors in the network have been considered as
target genes. The set of target genes has been considered as
the set source nodes. The set of genes apart from the target
genes has been considered as the set of sink nodes.
B. Selection of benchmark data
Data from NCBI sponsored Gene database, Aceview and
Uniprot database and Cosmic database have been curated
as benchmark data for Breast cancer and Lung cancer of
the species, Homosapiens. For this, the set of associated
genes corresponding to a particular disease case and species
has been fetched from these databases. These fetched genes
after removing duplicates have been taken as the benchmark
data for each disease. Similarly, data from NCBI sponsored
Gene database, Aceview, Uniprot database and literatures from
NCBI, Nature, Nucleic Acid Research have been compiled as
benchmark data for the species Rattus norvegicus [11], [12].
C. Formulation of the algorithm
1) Biological Background: Each gene g is expressed to a
particular level during the process of producing the ultimate
products called proteins and this level can be measured as
a numerical quantity, known as expression value, e(g) [13],
[14], [15], [16]. Also, each gene interacts with several genes
resulting in certain phenotypes [17]. With the advances in
the area of computational biology, molecular interactions can
be represented as a network by designating genes/proteins
as nodes and edges as associations between end nodes [18],
[19]. These associations have different aspects like physical
interactions, membership in the same pathway, co-expression
and literature co-occurrence [20], [21]. It reveals the fact that
two nodes may be linked together in different cases, resulting
in a network with multiple edges [22], [23], [24]. Also,
molecular interaction network consists of certain directional
links such as protein-protein interactions (bidirectional), TF-
DNA interactions (directional) and Phosphorylation events
(directional) [1], [7], [25], [9].
Expression levels or values of genes help to make distinction
between healthy and disease cases in view of the fact that
there is an increase or decrease in expression values of some
genes in many diseases from that of healthy individuals [26],
[27], [28]. When a particular gene’s expression value changes
between two groups of healthy and affected individuals, then
the gene is said to be differentially expressed [27], [16], [29].
Differentially expressed genes may lead to a disease state or
to a beneficial state.
2) Definitions: The set of genes that gives rise to a
particular disease state is termed as causal genes. The set of
probable genes of a certain disease is termed as candidate
causal genes. The set of candidate causal genes that are
bound by Transcription Factors is referred to as target genes
[1], [7], [3].
As described in Section II-C1, candidate causal genes are
connected together in a gene/protein network due to different
aspects. A disease state may be developed by the interference
of a target gene and a candidate causal gene in the normal
biological functions of a cell and this relationship between
a target gene and a candidate causal gene is known as
dependence [28]. The dependence between a target gene, t
and a candidate causal gene, c is computed as
δ(t, c) = P (e(t), e(c)) (1)
where, P (e(t), e(c)) is the Pearson’s correlation coefficient of
the expression values of genes t and c.
Genes with low values of δ and high values of δ are crucial
in molecular interactions [30]; so we consider the absolute
value of δ [4]. Similarly, in [1] and [7], the edge weight
for the edge in the molecular interaction network is taken
as the average of the absolute value of the dependence of
genes (end nodes of the edge) with the target gene. The edge
weights can be used as a measure of inferring causal genes
and corresponding pathways.
D. Formal notations and definitions
Let Gt be the set of target genes, Gcc be the set of candidate
causal genes and Gc be the set of causal genes.
The basic problem is to find Gc, the set of causal genes,
where Gc ⊆ Gcc and Gcc and Gt are known.
The fundamental decision problem here is
Does gcc ∈ Gc?
where gcc ∈ Gcc [or, is a candidate causal gene, a causal
gene].
Let us recall that gcc ∈ Gc if it has a role in disease, and
would be determined by the interactions it has with the target
genes, gt ∈ Gt, and other candidate genes which have a role
in the disease.
For each target gene gt, a weighted graph (network) is
defined with gt as the source, members in Gcc as the other
(non-source) nodes, and molecular interactions as the edges.
Edge weights reflect the role of the genes represented by the
end nodes in causing the disease. It may be realized at this
point that there would be |Gt| such graphs, each containing
|Gcc| + 1 nodes. Let (Gt, wt) be such a network for target
gene, gt.
Gt.V = {gt} ∪Gcc
Gt.E is defined by molecular interactions, as described next.
Let c(gcc, gt) = δ(gt, gcc).
Nodes in Gt.V would have had multiple edges between
them, as in Section II-C1. The molecular interaction network is
simplified, to get ordinary graphs, using the following method.
The weight function wt : Gt.V ×Gt.V → [0,+1] is defined
as,
wt(gx, gy) =
|c(gx, gt)|+ |c(gy, gt)|
2
(2)
where, gx, gy are candidate causal genes and gx ∼ gy (i.e.,
they have an interaction in any of the three ways outlined in
Section II-C1) [1], [7].
Thus, multiple edges defined in Section II-C1 get substituted
with a single weighted edge in Gt.
The genes at the endpoints of edges with higher edge
weights [1], [7] are said to have a role in the disease, or are
causal genes.
The weight of a path p from gt to gcc =
∑
e∈gt p;gcc wt(e).
The paths from gt to candidate causal genes having high
weight values are called dysregulated pathways. There may
be multiple dysregulated pathways in any (Gt, wt). It may
be recalled that there are |Gt| such (Gt, wt), or interaction
networks, and each typically contains multiple dysregulated
pathways.
Genes corresponding to nodes belonging to the dysregulated
pathways are called the causal genes. i.e., gcc ∈ Gc, if there
exists gt and a path p such that gt
p
; v and gcc ∈ p where, v
is a candidate causal gene, gt is a target gene and gt
p
; v is
a dysregulated pathway in (Gt, wt).
In the above description, the terms “high” edge weights and
“high” weighted paths have been used. As these adjectives are
abstract, they need to be quantified.
E. Towards a new algorithm
The problem defined in Section II-D is explained and stated
below, without abstract adjectives.
A protein network can be represented as an edge-weighted
directed graph with each gt as the source vertex and wt(u, v)
as the edge-weight between nodes u and v defined previously.
Nodes represent genes or proteins and edges represent molec-
ular interactions.
(Gt, wt) obtained for each gt ∈ Gt is further reduced, by
eliminating “low” weighted edges.
“High” and “low” are decided based on a threshold, which
is defined as follows.
In (Gt, wt), the threshold τ is defined as
τ =
∑
e∈Gt.Ewt(e)
|Gt.E| (3)
The set of edges to be removed, R, is computed as follows.
R = {e|e ∈ Gt.E ∧ wt(e) < τ} (4)
The edges in R are then removed from (Gt, wt) [9].
The paths having high path weights (as defined earlier) from
gt to all candidate causal genes, in graphs for all gt ∈ Gt
are the dysregulated pathways and all vertices belonging to
dysregulated pathways are causal genes.
Given n graphs (Gi, wi) with source vertex i ∈ Gt and
Gi.V = i ∪Gcc. Find Gc.
Gc = ∪∀(Gi,wi){gcc|wi(gcc, gi) > τ
∧ ∃p : gi p; gcc
∧ ∀e ∈ p wi(e) > τ} (5)
where, τ is the threshold value defined in Equation 3.
Find dysregulated pathways Dp as all the paths p satisfying
the above condition. i.e.,
Dp = {p|∀e ∈ p wi(e) > τ} (6)
It is inferred that every research work described in Section
I attempts to find the complete set Gc and all dysregulated
pathways. However, for realistic biological networks, the size
of the sets and the number of paths is very large for practical
computation [1], [7]. In order to get the results in reasonable
computation time, the following heuristic is used in this work.
“In a biological network, higher the degree of a node, more
relevant it is” [31], [32], where degree of a node is the number
of its neighboring edges. Degree of a node, v is denoted by
deg(v).
Hence, each time a path p ∈ Dp is explored in (Gi, wi),
a vertex gcc with deg(gcc) = δ(Gi, wi) is removed. δ(Gi, wi)
is the minimum degree of (Gi, wi). Let vδ be the node with
minimum degree in (Gi, wi). Then, (Gi, wi) is updated such
that Gi.V = Gi.V \ vδ . Next, a path, p ∈ Dp is traversed in
(Gi, wi) and repeat this process till |V | = k, where k is an
integer.
The process of removing vδ can be made efficient in terms
of execution time by mapping Gcc along with the degree
of each node, deg(gcc) to min-heap data structure. Min-heap
is the underlying data structure of priority queues with the
property of A[parent(u)] ≤ A[u], where u is a node other
than root node and parent(u) is the parent node of u [33].
Here, priority is given in terms of the decreasing order of
degree. Highest priority is assigned to the vertex vδ to ensure
that the vertex with the least degree is removed. Considering
each node and its degree in the molecular interaction network
as the elements of the min-heap, vδ is deleted by removing
the root node of the min-heap. Then, this data structure is
reorganized to bring the highest priority node or vδ at the root
[33] and the process specified earlier continues till the number
of nodes = k.
Each time vδ is removed, its adjacent edges are also
removed, thereby reducing the complex nature of biological
networks which in turn results in identification of relevant
genes and corresponding pathways within practical time in-
terval.
Now, definitions of Gc and Dp are updated as follows:
Gc = ∪∀(Gi,wi){gcc|wi(gcc, gi) > τ
∧ ∃p : gi p; gcc ∧ ∀e ∈ p wi(e) > τ
∧ ∃gcc : deg(gcc) > δ(Gi, wi)} (7)
Here, an additional characteristic of causal genes is incorpo-
rated apart from the attributes described in Equation 5: causal
genes tend to be higher degree nodes.
Dysregulated pathways Dp as all the paths p satisfying the
mentioned conditions. i.e.,
Dp = {p|∀e ∈ p wi(e) > τ ∧ ∃v ∈ p : deg(v) > deg(vδ)}
(8)
Finally, motivated by the approach in [9], randomized
rounding, an efficient approach to design an approximation
algorithm is done to fetch the most relevant paths in terms
of weight, wi(e) and degree, deg(gcc) in (Gi, wi). The ran-
domized rounding approach resulted in a factor ψηκ algorithm.
Here, ψ is the total number of paths in Ψ, where, Ψ is the
collection of all distinct paths in the reduced network. η is the
total number of distinct edges in Ψ and κ is the number of
occurrences of a randomly selected edge in Ψ.
Its underlying principle follows.
∑
∀e∈p wi(e) is calculated
for (Gi, wi), where p ∈ Dp . Let µp be max(
∑
∀e∈p wi(e))
in (Gi, wi). Dysregulated pathway is taken as the path having
value µp and the members of the pathway is taken as the
causal genes for (Gi, wi). Therefore, definitions of Gc and
Dp are reformed by adding the following attribute: causal
genes and thereby dysregulated pathways are constituted of
maximum weighted paths after randomized rounding. Final
definitions of Gc and Dp after joining all the mentioned
attributes together are as given below.
Gc = ∪∀(Gi,wi){gcc|wi(gcc, gi) > τ
∧ ∃p : gi p; gcc ∧ ∀e ∈ p wi(e) > τ
∧ ∃gcc : deg(gcc) > δ(Gi, wi)
∧ ∃p : ∀e ∈ p Σwi(e) = µp} (9)
Dysregulated pathways Dp as all the paths p satisfying the
stated conditions. i.e.,
Dp = {p|∀e ∈ p wi(e) > τ ∧ ∃v ∈ p : deg(v) > deg(vδ)
∧ ∀e ∈ p Σwi(e) = µp} (10)
F. Implementation and Validation of the results
Comparative study of the related works in literature and the
proposed method has been performed based on the accuracy
of results and the execution time. All these methods have been
implemented in Intel ®Core i7-3770 CPU @ 3.40GHz X 8
machine with memory (RAM) capacity of 16 GB by using the
programming languages R and C. Also, the effectiveness of the
Algorithm 1 has been explored by using Reactome Pathway
Database to provide its biological significance.
1) Analysis based on τ and k: As the threshold defined
in 3, is quite critical for removing the low-weighted edges,
its effect on identifying causal genes and dysregulated path-
ways has been simulated. For this, apart from implementing
Algorithm 1, an algorithm without using steps 4, 5 and 6
in Algorithm 1 has been implemented. Also, Algorithm 1
has been implemented against different values of k which is
defined in Section II-E for the datasets.
III. DISCUSSION AND RESULTS
A. Approximation algorithm with graph reduction
Pseudo code for the algorithm to identify causal genes and
dysregulated pathways is given in Algorithm 1. The algo-
rithm considers a molecular interaction network with multiple
sources and sinks. Source set is the set of target genes and
sink set is the set of candidate causal genes other than target
genes. Proof of the approximation factor is given in Appendix
??.
B. Implementation and Validation of the results
All the related works in literature and the proposed algo-
rithm have been implemented as specified in Section II-A on
multiple datasets. For Breast cancer dataset, Gt consists of 41
genes and Gcc consists of 309 genes, for Lung cancer dataset,
Gt consists of 7 genes and Gcc consists of 70 genes and for
Pancreatic cancer dataset, Gt consists of 46 genes and Gcc
consists of 140 genes. (Gt, wt) have 8403 edges and 350 nodes
with a total of 41 such graphs for Breast cancer dataset, 466
edges and 77 nodes with a total of 7 such graphs for Lung
cancer dataset and 729 edges and 186 nodes with a total of
46 such graphs for Pancreatic cancer dataset. Benchmark data
as specified in Section II-B have been obtained for the cases
Breast cancer, Lung cancer and Pancreatic cancer as 26 genes,
21 genes and 83 genes respectively.
Let us denote Breast cancer dataset as dataset I, Lung cancer
dataset as dataset II and Pancreatic cancer dataset as dataset
III.
1) Simulation study based on τ : The effect of τ on
identifying causal genes and dysregulated pathways has been
simulated by considering multiple graphs with SLCO2A1 as
source for a subset of sink nodes on dataset I, Cdk6 as source
for a subset of sink nodes on dataset II and Acaca as source
Algorithm 1 Infer causal genes and dysregulated pathways
Input: n graphs (Gi, wi) with source vertex i ∈ Gt and sink
vertex gcc ∈ Gcc
Output: Gc and Dp
1: for all i ∈ Gt do
2: for all gcc ∈ Gcc do
3: s← gcc
4: Calculate τ
5: Find R
6: Remove R from (Gi, wi)
7: repeat
8: Ψ = Ψ ∪ Findpath((Gi, wi), i)
9: until (|V | = k)
10: ψ ← |Ψ|
11: if ψ = 0 then
12: goto step 1
13: else if ψ = 1 then
14: Dp = Ψ
15: Find Gc
16: goto step 1
17: else
18: Find η, total number of distinct edges in Ψ
19: Randomly pick an edge, e from a path in Ψ
20: Calculate κ, number of occurrences of e in Ψ
21: r ← ηκψ
22: for i = 1 to r do
23: Randomly select a path p in Ψ
24: Calculate
∑
∀e∈p wi(e)
25: end for
26: Dp ← Path with value µp
27: Find Gc
28: end if
29: end for
30: end for
for a subset of sink nodes on dataset III, as specified in Section
II-F1. The results are summarized and tabulated in Table II.
Dataset # Causal Genes Execution Time
I [86][87] [435.35 Sec.][737.33 Sec.]
II [24][35] [1.503 Sec.][1.893 Sec.]
III [8][9] [45.5 Sec.][800.119 Sec.]
TABLE II: Effect of τ with the order [with τ ][without τ ]
There is a slight increase in the number of causal genes
identified in the method without using τ ; but, it compromises
on execution time while considering all the genes.
2) Analysis based on k: Algorithm 1 has been implemented
against different values of k as defined in Section II-E for
the datasets. Considering the size of the datasets, for dataset
I, a subgraph of (Gt, wt) has been considered by selecting
first 100 genes after sorting p-value, resulting in 8 graphs of
432 edges and 74 nodes with benchmark data consisting of
procedure Findpath((Gi, wi), v)
if v = s then
p = p ∪ v
Ψ← p
G1.V = Gi.V \ {i, s}
Calculate deg(gcc) for all gcc ∈ G1.V
Assign priority based on decreasing order of degree
Make a min− heap for (G1)
Find vδ
Delete vδ from min− heap
Update Gi.V = Gi.V \ vδ
else
for all neighbours adj of v do
if adj is unexplored then
p = p ∪ v
F indpath((Gi, wi), adj)
end if
end for
end if
end procedure
10 genes. The receiver-operating characteristic (ROC) analysis
has been used to compare the performance of the algorithm
under various values of k. The values of k are selected as 10%
of |V |, 20% of |V |, 30% of |V | and 40% of |V |. The ROC
curve plots the true positive rate (TPR) / sensitivity versus
the false positive rate (FPR) / (100-specificity) where, TPR is
the percentage of causal genes which are correctly identified
based on benchmark dataset and FPR is the percentage of
causal genes which are not present in the benchmark dataset.
To compare different curves obtained by ROC analysis, the
area under curve (AUC) for each curve has been calculated,
which is given in Table III. Higher the value of AUC, better
the result is. Also, the execution time for each case is taken
and it is summarized in Table IV. When the ROC curve and
execution time are compared, k=10% of |V | has shown better
performance and it has been selected as the cut-off value in
Algorithm 1 provided overall accuracy is same in all cases.
Values of k Dataset I Dataset II Dataset III
10% of |V | 0.0294 0.6932 0.656
20% of |V | 0.0294 0.5263 0.694
30% of |V | 0.0294 0.3982 0.579
40% of |V | 0.0294 0.4463 0.552
TABLE III: AUC for different values of k
Values of k Dataset I Dataset II Dataset III
10% of |V | 0.16 6.68 90.291
20% of |V | 1.5 9.57 148.28
30% of |V | 10.9 10.38 167.206
40% of |V | 14.06 14.24 1637
TABLE IV: Execution time (Seconds) for different values of
k
Fig. 1: Comparison based on the accuracy of results
C. Measuring the accuracy of results and Analysis based on
the execution time
Accuracy is defined as the measurement of closeness be-
tween the benchmark data and the actual results. It is calcu-
lated as the percentage of causal genes which are correctly
identified based on benchmark dataset. Comparison based on
the accuracy of results is given in Figure 1 and the execution
time is given in Table V.
Approaches Dataset I Dataset II Dataset III
Random walk approach 65 (Min.) 5 (Sec.) 1 (Min.)
eQED approach 33 (Min.) 4 (Sec.) 0.8 (Min.)
Current flow approach 37 (Min.) 1801 (Hours) 1226 (Min.)
Matrix inversion approach 34 (Min.) 1789 (Hours) 1212 (Min.)
Randomized rounding approach 4114 (Min.) 53 (Hours) 1.73 (Min.)
Rounding with min-heap 2155 (Min.) 8.61 (Sec.) 1.12 (Min.)
TABLE V: Comparison based on the execution time
Observations made based on these results are given next. In
random walk approach, the Pearson’s correlation coefficient of
the gene expression levels of genes at each node and the target
gene is calculated and transition probability has obtained using
this value. Random walk based on transition probabilities is
done multiple times. Disease causing genes including their
pathways are obtained as the result. Random walk approach
takes less amount of execution time, but the number of genes
identified and the accuracy of results are less. The molecular
interaction is considered as an electric circuit according to
other approaches in literature. The conductance of each link
is calculated based on the Pearson’s correlation coefficient of
the gene expression levels of genes at each node and target
gene. The Kirchhoff’s current law and Ohm’s law are utilized
to obtain voltages. The current is calculated using Ohm’s law
for each edge in the network. Disease causing genes and dys-
regulated pathways are identified using each of these methods.
eQED approach takes least amount of execution time, but
gives lesser number of genes and low accuracy compared to
methods other than random walk approach. Electric circuit
approach with multiple sources and sinks and fast iterative
matrix inversion return same number of disease causing genes
with same accuracy. Here, genes receiving current of at least
70% of the maximum current among all genes are considered
in each iteration and thereby its execution time is greater in
most of the cases. Since, fast iterative matrix inversion uses
fourth order iterative method, execution time is less compared
to electric circuit approach with multiple sources and sinks.
Approximation algorithm outperforms other methods in terms
of the number of disease causing genes identified and the
accuracy of results. But, it takes much more time compared
to random walk approach and eQED approach. Here, before
applying randomized rounding, all possible paths are identified
which in turn results in increased execution time.
The proposed algorithm, Approximation algorithm with
graph reduction has been implemented on multiple datasets
and the sets of causal genes and associated pathways for the
disease cases have been identified. Initially, a set of less-
weighted edges are removed. Then, a set of vertices are
removed together with the exploration of a set of distinct
simple paths by making sure that a vertex of least degree is
deleted. Min-heap data structure is utilized for time efficient
vertex removal. This process repeats k times with its value as
10% of |V |. Finally, most relevant paths are identified using
randomized rounding. This newly proposed approximation
algorithm with graph reduction defeats all other methods by
identifying more number of genes within less time interval.
The sets of all newly identified disease causing genes apart
from the known genes in the benchmark datasets as well as
the resultant sets of identified causal genes and dysregulated
pathways for all the datasets are given in the Supplementary
material.
IV. CONCLUSION AND FUTURE SCOPE
Computationally intensive process of identifying causal
genes and related pathways from the huge molecular interac-
tion networks has been addressed in this paper. The huge size
of the molecular interaction network is reduced by retaining
more relevant nodes and edges in terms of edge-weights and
connectivity. Then, most appropriate nodes, thereby paths in
terms of these parameters are selected by using the concept
of approximation. Experimentations proved that the newly
proposed approximation algorithm with graph reduction out-
performs all other methods by identifying more number of
genes within lesser time.
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